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Background
Human leukocyte antigen (HLA) class I alleles B*27 and
B*57 are associated with protection against HIV-1 dis-
ease progression, but factors modulating the HLA pro-
tective effect remain unclear.
Methods
Clonality of tetramer-sorted HIV-1 epitope-specific CD8 T
cells from HIV-1 elite controllers and chronic progressors
expressing HLA B*27 or B*57 were determined by T cell
receptor (TCR) gene sequencing. Polyfunctionality, prolif-
eration, avidity and differentiation phenotypes were ana-
lyzed by flow cytometry. Recognition of a GFP reporter
cell line or autologous CD4 T cells infected with HIV-1
containing known mutations by HIV-1 epitope-specific
bulk CD8 T cells or clonotypic CD8 T cell clones was ana-
lyzed by flow cytometry or analysis of p24 production.
Immunological synapses between different CD8 T cell
clones and infected target cells and lytic granule loading
and delivery on a per cell basis were examined using
three-dimensional confocal microscopy.
Results
HLA-B*27-restricted CD8 T cells in controllers and pro-
gressors are quantitatively similar but clearly differentiate
based on the ability to inhibit virus replication through
targeting of the immunodominant Gag epitope. This in
turn is associated with distinct TCR clonotypes, which are
characterized by superior control of HIV-1 replication in
vitro, greater cross-reactivity against epitope variants, and
enhanced perforin expression and delivery at the immuno-
logical synapse. Clonotype-specific differences in antiviral
efficacy were also observed for an immunodominant
HLA-B*57 restricted response in controllers and
progressors.
Conclusion
These data indicate that the efficacy of protective alleles is
modulated by specific TCR clonotypes that are selected in
natural infection, and provide a functional explanation for
divergent HIV-1 outcomes in persons with protective
HLA alleles. Efforts to define the factors that contribute to
junctional rearrangement of more effective TCR may be of
critical importance for T cell vaccine design and therapeu-
tic strategies for highly variable pathogens like HIV-1.
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